Chang C H, Lin P J, Chu Y, Lee Y S
Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Chang Gung Medical College, Taipei, Taiwan, Republic of China.
J Am Coll Cardiol. 1997 Mar 1;29(3):681-7. doi: 10.1016/s0735-1097(96)00557-8.
Experiments were designed to determine whether coronary endothelial dysfunction after cardiac global ischemia and reperfusion could be prevented by warm blood cardioplegic solution.
The coronary endothelium produces endothelium-derived relaxing factor (EDRF) to prevent vasospasm and thrombosis. After ischemia and reperfusion, endothelium-dependent relaxation (EDR) is diminished as a result of G-protein dysfunction.
Dogs were exposed to extracorporeal circulation in 37 degrees C (group 1) or 28 degrees C (groups 2 and 3). The heart was ischemic for 120 min while continuous warm blood cardioplegic solution (group 1) or intermittent cold (4 degrees C) crystalloid cardioplegic solution was not used in group 3 animals. The heart was then allowed to function for 60 min of reperfusion.
Endothelium-derived relaxation in response to acetylcholine, adenosine diphosphate and sodium fluoride of the coronary rings of group 1 was significantly different from that of groups 2 and 3 but was not significantly different from that of group 4. In contrast, EDR in response to the receptor-independent calcium ionophore agonist A23187 was not significantly different between the four groups. Scanning electron microscopic studies showed that platelet adhesion and aggregation, area of microthrombi, disruption of endothelial cells and separation of the intercellular junction could be found in coronary segments of groups 2 and 3 but not in vessels of groups 1 and 4.
These experiments suggest that cardiac global ischemia and reperfusion impair receptor-mediated release of EDRF from the coronary endothelium with G-protein dysfunction. This type of coronary endothelial dysfunction can be prevented by continuous anterograde infusion of warm blood cardioplegic solution during global ischemia.
设计实验以确定温血心脏停搏液是否能预防心脏全心缺血再灌注后的冠状动脉内皮功能障碍。
冠状动脉内皮产生内皮衍生舒张因子(EDRF)以预防血管痉挛和血栓形成。缺血再灌注后,由于G蛋白功能障碍,内皮依赖性舒张(EDR)减弱。
将犬暴露于37℃(第1组)或28℃(第2组和第3组)的体外循环中。心脏缺血120分钟,第1组持续输注温血心脏停搏液,第3组动物未使用间歇性冷(4℃)晶体心脏停搏液。然后使心脏进行60分钟的再灌注。
第1组冠状动脉环对乙酰胆碱、二磷酸腺苷和氟化钠的内皮衍生舒张与第2组和第3组有显著差异,但与第4组无显著差异。相反,对受体非依赖性钙离子载体激动剂A23187的EDR在四组之间无显著差异。扫描电子显微镜研究表明,在第2组和第3组的冠状动脉段可发现血小板粘附和聚集、微血栓面积、内皮细胞破坏和细胞间连接分离,而在第1组和第4组的血管中未发现。
这些实验表明,心脏全心缺血再灌注通过G蛋白功能障碍损害冠状动脉内皮中受体介导的EDRF释放。在全心缺血期间持续顺行输注温血心脏停搏液可预防这种类型的冠状动脉内皮功能障碍。